Project Grant R03TR004798
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$159K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $455,000.00 to the Children's Research Institute to develop new therapeutic protocols for reducing sepsis mortality in pediatric populations. The key products and services to be delivered include: An AI-guided early identification tool for rapid sepsis detection, 2) Sepsis phenotyping and digital twin patient modeling to...
The National Institute of Child Health and Human Development awarded a Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) in the amount of $224,083 to Seattle Children's Hospital on May 1, 2025. The grant supports research on the use of oscillometry for evaluating pulmonary function following pediatric acute respiratory failure, which is a major cause of critical illness in U.S. children. The research aims to advance medical knowledge and develop new...
This federal Project Grant award, totaling $721,728.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The objective is to investigate the relationship between persistent viral infections and outcomes in pediatric sepsis patients, with a focus on evaluating how viral status affects sepsis phenotypes, clinical outcomes, and response to immunomodulatory therapies. The research will leverage...
This Project Grant award of $340,000.00 from the Maternal and Child Health Bureau of the Health Resources and Services Administration (CFDA 93.110 - Maternal and Child Health Federal Consolidated Programs) will support the Regents of the University of Michigan in conducting a 5-year pediatric pulmonary research and healthcare services program. The award, effective from July 1, 2025 to June 30, 2030, will enable the University of Michigan to leverage its expertise in maternal and child health...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training Program provides $179,475 to The Children's Hospital of Philadelphia (CHOP) from June 1, 2025 to May 31, 2028. The grant supports research to define and prospectively evaluate a model for identifying prognostic molecular subphenotypes of sepsis in pediatric patients, and to determine the impact of JAK/STAT inhibition on reversing immune...
This federal Project Grant award for $163,080.00 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports a 5-year research project to investigate the regulatory T cell response in children with severe viral pneumonia. Key objectives include determining whether juvenile regulatory T cells have impaired reparative functions during severe viral pneumonia, assessing how the age-specific lung...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $781,129 to The Regents of the University of California, San Francisco (UCSF) to conduct a prospective, multicenter cohort study of 400 critically ill children with acute respiratory failure. The key objectives are to: 1) independently validate the performance of UCSF's existing integrated host/microbe...
This Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training) provides $418,750.00 in funding to The Feinstein Institutes for Medical Research to conduct research on T cell receptor-mediated T cell activation in neonatal and pediatric sepsis. The research aims to investigate how T cell memory responses and sepsis-associated factors such as angiotensin II signaling influence T cell-antigen presenting cell interactions...
This $134,123 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support research investigating the biology of pulmonary fibrosis in pediatric hematopoietic cell transplant patients. The primary objectives are to identify transcriptomic and proteomic signatures that differentiate patients with and without pulmonary fibrosis, as well as predictors of future pulmonary fibrosis development. This will be accomplished...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, supports research aimed at advancing precision medicine approaches for the treatment of acute respiratory distress syndrome (ARDS) and sepsis. The $1,147,992 award, effective from April 1, 2025 to March 31, 2032, will enable the Regents of the University of California, San Francisco (UCSF) to conduct a multifaceted research program to address key unanswered questions...